Prostaglandin D2 inhibits C2C12 myogenesis

Molecular and Cellular Endocrinology
Pedro VeliçaChris M Bunce

Abstract

Muscle repair following injury is preceded by a rapid inflammatory response with myoblasts being exposed to high levels of prostaglandin D(2) (PGD(2)) from invading leukocytes. We demonstrate that PGD(2) strongly inhibits C2C12 myogenesis as measured by cell fusion, creatine kinase activity and MyoD, myogenin and alpha-actin expression. Inhibition of myogenesis required micromolar PGD(2) concentrations and was independent of the known PGD(2) receptors DP1 and DP2. Unlike its cyclopentenone derivative 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)), PGD(2) did not generate toxic mitochondrial superoxide indicating that the inhibition of myogenesis is not mediated by generation of high concentrations of PGD(2)-derived 15d-PGJ(2). Thus our observations provide evidence for a novel PGD(2) signalling mechanism during muscle repair exclusively mediated by high inflammatory associated PGD(2) concentrations. These findings indicate a complex interplay between myoblasts and inflammatory cells during the repair process and have implications for the use of non-steroidal anti-inflammatory drugs in the treatment of muscle injuries.

Citations

Mar 31, 2012·American Journal of Physiology. Cell Physiology·Mark E IssaKerry B Goralski
Jan 29, 2014·Nature Reviews. Rheumatology·Marina Korotkova, Ingrid E Lundberg
Jun 4, 2013·Prostaglandins & Other Lipid Mediators·Brian T KalishDipak Panigrahy
Sep 14, 2011·Biochemical and Biophysical Research Communications·Jaemin Jeong, Irina M Conboy
Mar 30, 2017·Revista da Associação Médica Brasileira·Phablo AbreuSandro Massao Hirabara
Oct 19, 2012·American Journal of Physiology. Cell Physiology·James F Markworth, David Cameron-Smith
Feb 1, 2015·Blood·Jorge J CastilloRoberto N Miranda
Oct 15, 2011·Muscle & Nerve·Pedro Veliça, Chris M Bunce
Sep 7, 2019·International Journal of Molecular Sciences·Chenglin MoMarco Brotto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.